Richard E. Buller - Concepedia

Author

Richard E. Buller

University of Iowa Hospitals and Clinics

Also Known As

P. Baade, R E Buller, R. E. Buller, R.E Buller, R.E. BULLER, R.E. Buller, RICHARD BULLER, RICHARD E. BULLER, Richard Buller, Richard E Buller

142

Publications

6.3K

Citations

H-Index

117

Concepts

All Affiliations

University of Iowa Hospitals and Clinics University of Iowa Gynecologic Oncology Group University of California, Irvine Medical Center Baylor College of Medicine

About

Richard E. Buller is an author at University of Iowa Hospitals and Clinics specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	61	3.3K
2	Public Health	11	11	772
3	Health Sciences	6	6	253
4	Natural Sciences	4	4	150
5	Nursing	1	1	11

Richard E. Buller

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Simultaneously Detected Endometrial and Ovarian Carcinomas— A Prospective Clinicopathologic Study of 74 Cases: A Gynecologic Oncology Group Study Richard J. Zaino, Charles Whitney, Mark F. Brady, Gynecologic Oncology Tumoral PathologyGynecological SurgeryMedicineGynecologyPathology	2001	321
Extraovarian Peritoneal Serous Papillary Carcinoma: A Case-Control Retrospective Comparison to Papillary Adenocarcinoma of the Ovary Jeffrey D. Bloss, Shu‐Yuan Liao, Richard E. Buller, Gynecologic Oncology Surgical OncologyTumoral PathologyGynecological SurgeryGynecologySurgery	1993	266
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Brian C. Cooper, Justine M. Ritchie, Carrie L W Broghammer, PubMed	2002	171
Surgical Management of Cervical Cancer Complicating Pregnancy: A Case–Control Study Anil K. Sood, Joel I. Sorosky, Sharon Krogman, Gynecologic Oncology Gynecologic SurgeryCervical Cancer ManagementGynecological SurgeryCervical CancerCervical Health	1996	166
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer Richard E. Buller, Ingo B. Runnebaum, Beth Y. Karlan, Cancer Gene Therapy MedicineGynecologyRecurrent Ovarian CancerTumor SuppressorGene Replacement	2002	163
Vascular endothelial growth factor and social support in patients with ovarian carcinoma Susan K. Lutgendorf, Erica L. Johnsen, Brian C. Cooper, Cancer	2002	159
Progesterone-binding components of chick oviduct. VIII. Receptor activation and hormone-dependent binding to purified nuclei. Richard E. Buller, D O Toft, William T. Schrader, Journal of Biological Chemistry	1975	143
Quality of life and mood in women with gynecologic cancer Susan K. Lutgendorf, Barrie Anderson, Philip M. Ullrich, Cancer	2001	140
Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian Cancer Richard E. Buller, Anil K. Sood, Thomas A. Lallas, JNCI Journal of the National Cancer Institute	1999	132
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma Mark S. Shahin, Jonathon H. Hughes, Anil K. Sood, Cancer	2000	129

Page 1